Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00439348 · ClinicalTrials.gov registry record · NA
Over-the-Counter Medication Usage
A NA study of Drugs, Non-Prescription and Medication Systems, sponsored by AdventHealth.
- Completed
- Registry status
- NA
- Development phase
- 246
- Enrollment target
- 1
- Study location
NCT00439348: Completed NA study of Drugs, Non-Prescription and Medication Systems, sponsored by AdventHealth.
NCT00439348 is a NA study of Drugs, Non-Prescription and Medication Systems that has completed, run by AdventHealth. The registered enrollment target is 246 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00439348, a NA study of Drugs, Non-Prescription and Medication Systems, has completed, sponsored by AdventHealth.
- COMPLETED
- Registry status
- NA
- Development phase
- 246 participants
- Enrollment target
- 1
- Study location
Study Summary
There are several benefits of over-the-counter medications, yet there is little research evaluating how to increase patient compliance when a health care provider suggests an over-the-counter (OTC) medication. We are evaluating two types of physician directions to see which increases patient compliance with OTC medications.
Conditions Studied
Interventions
- BEHAVIORAL Verbal advice
- BEHAVIORAL Prescription
Study Locations (1)
Florida
- Loch Haven Ob/Gyn Group - Orlando
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 246 participants |
| Start Date | 2007-02 |
| Est. Completion | 2009-02 |
| Phase | NA |
What the finished NCT00439348 record still lists
NCT00439348 is an interventional study that assigns participants to a tested intervention. The registered 246 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 2 conditions, with Drugs, Non-Prescription appearing as the primary indexed condition, and to 2 interventions - of which Verbal advice is the first listed.
NCT00439348 reports a single indexed study location in Florida.
Frequently Asked Questions
What is clinical trial NCT00439348 about?
NCT00439348 is a clinical study titled "Over-the-Counter Medication Usage". There are several benefits of over-the-counter medications, yet there is little research evaluating how to increase patient compliance when a health care provider suggests an over-the-counter (OTC) medication. We are evaluating two types of physician directions to see which increases patient complia...
What is the current status of trial NCT00439348?
This trial is currently completed. It is a NA study. The enrollment target is 246 participants. The study started on 2007-02. Estimated completion is 2009-02.
What conditions does trial NCT00439348 study?
This clinical trial studies the following conditions: Drugs, Non-Prescription, Medication Systems.
What interventions are being tested in trial NCT00439348?
The interventions under investigation include: Verbal advice (BEHAVIORAL), Prescription (BEHAVIORAL).
Who is sponsoring clinical trial NCT00439348?
This trial is sponsored by AdventHealth, which has 95 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00439348 being conducted?
This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00439348's enrollment target sits among peer trials
246 436th of 2000 higher than 1,565 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04973605 · 246 participants · Phase 1
A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma
- NCT06395168 · 246 participants · NA
Mayo Clinic Health System Northwest Wisconsin Integrated Maternal Postpartum Appointment Combination
- NCT07048769 · 246 participants · Phase 4
Paracervical Block for Pain Reduction in Saline Infusion Sonograms
- NCT07176650 · 246 participants · Phase 1
Phase I Clinical Study To Evaluate Pharmacokinetic Profile, Safety, Efficacy and Immunogenicity Of Ipilimumab Biosimilar HLX13 Vs. YERVOY® (US-Sourced YERVOY®) As A First-Line Treatment For Patients With Unresectable Hepatocellular Carcinoma
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia